spacer
home > ict > spring 2019 > the patient data paradigm
PUBLICATIONS
International Clinical Trials

The Patient Data Paradigm

Translational research, multifaceted collaboration, and nextgeneration trial designs are helping to progress the reality of precision medicine in cancer treatment. Patient data − in particular, genomic data and pharmacogenomic data − have become the centre point of research. However, unless we remember to view patient contribution in medical research with the patient’s interest at heart, we may risk failing in the attempt to implement precious patient data effectively.

Cancer therapy has seen one of the most revolutionary transformations in decades. A deeper understanding of the disease at a molecular level has shifted the cancer treatment paradigm, and personalised cancer medicines are now promising to deliver the right drug to the right person at the right time, tackling tumour behaviour with precise mechanisms of action.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Dr Aldo Poli has over 30 years’ experience in the pharma industry, with a deep expertise in methodology and statistics. He is co-founder and CEO of OPIS, a full service CRO founded in 1998 that focuses on clinical trial management for multicountry Phase 1-4 trials, non-interventional studies, and medical device investigations.
spacer
Dr Aldo Poli
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Switzerland overtakes Germany as Europe’s biggest drug delivery innovator, with the UK and France close behind

Paris, 19th August 2019: As predicted by the ‘European drug delivery and packaging’ report earlier this year, new data shows innovation in drug delivery is accelerating across Europe – with provisional findings from the Pharmapack Innovation Index (2020) showing that Switzerland has over taken Germany as Europe’s most innovative drug delivery market.
More info >>

White Papers

Industrial Security in the Pharmaceutical Sector

COPA-DATA

As an attractive target for cyber attacks, pharmaceutical companies need to understand cyber security, assess weak points and implement the appropriate security measures. This white paper describes some of the most effective industrial security tools pharmaceutical companies have at their disposal in the era of Industry 4.0.
More info >>

 
Industry Events

CPhI & P-MEC India

26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India

As the pharma industry looks increasingly towards India forhigh quality, low   cost pharma solutions, CPhI & P-MEC Indiais the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer. At CPhI & P-MEC India, you will meet the movers and shakers from India’s pharma machinery, technology and ingredients industries, giving you a competitive advantage that will help grow your business.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement